A Multicenter Cohort Study of the Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents

Trial Profile

A Multicenter Cohort Study of the Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Dec 2017

At a glance

  • Drugs Micafungin (Primary) ; Antifungals
  • Indications Mycoses
  • Focus Adverse reactions
  • Acronyms MYCOS
  • Sponsors Astellas Pharma Europe Ltd
  • Most Recent Events

    • 01 Sep 2017 Planned End Date changed from 1 Nov 2019 to 1 Jan 2020.
    • 01 Sep 2017 Planned primary completion date changed from 1 Nov 2019 to 1 Jan 2020.
    • 28 Feb 2017 Planned End Date changed from 1 Nov 2020 to 1 Nov 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top